Company: DRTSW
Filing Date: 2025-06-23
Form Type: F-3
Source: 0001213900-25-056744
Chunk: 23

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-06-23
Form: F-3
Chunk 23
---
 update, substitute, or change the information contained in this prospectus, including the identity of each Selling Shareholder
and the number of ordinary shares registered on its behalf. A Selling Shareholder may sell all, some or none of such securities in this
offering. See “Plan of Distribution.”

The information in the table
below is based upon information provided by the Selling Shareholders. The securities owned by the Selling Shareholders named below do
not have voting rights different from the securities owned by other securityholders.

|                                 |     |           |            |     |                  |           |     |                 |            |     | Percentage of   |       |   |
|                                 |     |           |            |     |                  |           |     |                 |            |     | Outstanding     |       |   |
|                                 |     | Number of |            |     | Number of        |           |     | Number of       |            |     | Ordinary Shares |       |   |
|                                 |     | Ordinary  |            |     | Ordinary Shares  |           |     | Ordinary Shares |            |     | Owned After     |       |   |
| Name of Selling Shareholder     |     | Shares    |            |     | Being Offered(3) |           |     | After Offering  |            |     | Offering        |       |   |
| Oramed Ltd.(1)                  |     |           | 17,435,051 |     |                  | 3,237,000 |     |                 | 14,198,051 |     |                 | 16.12 | % |
| A & M Construction Co., Inc.(2) |     |           |    226,202 |     |                  |   226,202 |     |                 |          — |     |                 |     — |   |

| (1) | Consists of (i) 14,198,051 ordinary shares held by Oramed                                                                      
 and (ii) 3,237,000 ordinary shares issuable upon the exercise of the IR/PR Warrants held by Oramed. Oramed’s principal offices 
 are located at 20 Mamilla Ave., 3rd Floor Jerusalem, Israel 9414904.                                                           |

| (2) | Consists of 226,202 ordinary shares held by A & M Construction                                                                    
 upon issuance pursuant to the Design-Build Agreement. A & M Construction’s principal offices are located at 36 West Water